ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL2097081
CHEMBL2097081
Compound Name NITROPRUSSIDE
ChEMBL Synonyms NITROPRUSSIDE
Max Phase 4 (Approved)
Trade Names
Molecular Formula C5FeN6O-2

Sources

  • PubChem BioAssays
  • Scientific Literature
  • WHO Anatomical Therapeutic Chemical Classification

Molecule Features

CHEMBL2097081 compound icon
Drug Type:Synthetic Small Molecule Rule of Five:N First In Class:N Chirality:Achiral Molecule Prodrug:N Oral:N Parenteral:N Topical:N Black Box:N Availability Type:Unknown

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
Depressive DisorderD003866EFO:0003761unipolar depression2ClinicalTrials
Myocardial InfarctionD009203EFO:0000612myocardial infarction2ClinicalTrials
HypertensionD006973EFO:0000537hypertension4ATC
ClinicalTrials
HypotensionD007022EFO:0005251hypotension2ClinicalTrials

Clinical Data

ClinicalTrials.gov NITROPRUSSIDE
The Cochrane Collaboration NITROPRUSSIDE

Compound Bioactivity Summary

Compound Assay Summary

Compound Target Summary

Compound Cross References

ATC C - CARDIOVASCULAR SYSTEM
C02 - ANTIHYPERTENSIVES
C02D - ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
C02DD - Nitroferricyanide derivatives
C02DD01 - nitroprusside

ChemSpider ChemSpider Identifier not yet assigned
DailyMed sodium nitroprusside
PubChem SID: 29217813
spacer
spacer